The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
QT prolongation through hERG K+ channel blockade: Current knowledge and strategies for the early prediction during drug development
Abstract
Prolongation of the QT interval of the electrocardiogram is a typical effect of Class III antiarrhythmic drugs, achieved through blockade of potassium channels. In the past decade, evidence has accrued that several classes of drugs used for non‐cardiovascular indications may prolong the QT interval with the same mechanism (namely, human ether‐à‐go‐go‐related gene (hERG) K+ channel blockade). The great interest in QT prolongation is because of several reasons. First, drug‐induced QT prolongation increases the likelihood of a polymorphous ventricular arrhythmia (namely, torsades de pointes, TdP), which may cause syncope and degenerate into ventricular fibrillation and sudden death. Second, the fact that several classes of drugs, such as antihistamines, fluoroquinolones, macrolides, and neuroleptics may cause the long QT syndrome (LQTS) raises the question whether this is a class effect (e.g., shared by all agents of a given pharmacological class) or a specific effect of single agents within a class. There is now consensus that, in most cases, only a few agents within a therapeutic class share the ability to significantly affect hERG K+ channels. These compounds should be identified as early as possible during drug development. Third, QT prolongation and interaction with hERG K+ channels have become surrogate markers of cardiotoxicity and have received increasing regulatory attention. This review briefly outlines the mechanisms leading to QT prolongation and the different strategies that can be followed to predict this unwanted effect. In particular, it will focus on the approaches recently proposed for the in silico screening of new compounds. © 2004 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dewar, M. J. S., Zoebisch, E. G., Healy, E. F., & Stewart, J. J. P. (1985) · Journal of the American Chemical Society · doi:10.1021/ja00299a024 · Cited by 13,074
The Structure of the Potassium Channel: Molecular Basis of K + Conduction and Selectivity
Doyle, D. A., Cabral, J. M., Pfuetzner, R. A., Kuo, A., Gulbis, J. M., Cohen, S. L., Chait, B. T., & MacKinnon, R. (1998) · Science · doi:10.1126/science.280.5360.69 · Cited by 6,807
Mohamadi, F., Richards, N. G. J., Guida, W. C., Liskamp, R., Lipton, M., Caufield, C., Chang, G., Hendrickson, T., & Still, W. C. (1990) · Journal of Computational Chemistry · doi:10.1002/jcc.540110405 · Cited by 3,757
Semianalytical treatment of solvation for molecular mechanics and dynamics
Still, W. C., Tempczyk, A., Hawley, R. C., & Hendrickson, T. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00172a038 · Cited by 3,643
Goodford, P. J. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00145a002 · Cited by 2,634
Sanguinetti, M. C., Jiang, C., Curran, M. E., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90340-2 · Cited by 2,423
p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure
Hansch, C., & Fujita, T. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a035 · Cited by 2,313
The Effect of Structure upon the Reactions of Organic Compounds. Benzene Derivatives
Hammett, L. P. (1937) · Journal of the American Chemical Society · doi:10.1021/ja01280a022 · Cited by 2,249
ADMET in silico modelling: towards prediction paradise?
van de Waterbeemd, H., & Gifford, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1032 · Cited by 1,863
X-ray structure of a voltage-dependent K+ channel
Jiang, Y., Lee, A., Chen, J., Ruta, V., Cadene, M., Chait, B. T., & MacKinnon, R. (2003) · Nature · doi:10.1038/nature01580 · Cited by 1,797
REDFERN, W., CARLSSON, L., DAVIS, A., LYNCH, W., MACKENZIE, I., PALETHORPE, S., SIEGL, P., STRANG, I., SULLIVAN, A., & WALLIS, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00846-5 · Cited by 1,532
MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia
Abbott, G. W., Sesti, F., Splawski, I., Buck, M. E., Lehmann, M. H., Timothy, K. W., Keating, M. T., & Goldstein, S. A. N. (1999) · Cell · doi:10.1016/s0092-8674(00)80728-x · Cited by 1,354
Crystal structure and mechanism of a calcium-gated potassium channel
Jiang, Y., Lee, A., Chen, J., Cadene, M., Chait, B. T., & MacKinnon, R. (2002) · Nature · doi:10.1038/417515a · Cited by 1,332
Spectrum of Mutations in Long-QT Syndrome Genes: KVLQT1 , HERG , SCN5A , KCNE1 , and KCNE2
Splawski, I., Shen, J., Timothy, K. W., Lehmann, M. H., Priori, S., Robinson, J. L., Moss, A. J., Schwartz, P. J., Towbin, J. A., Vincent, G. M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1178 · Cited by 1,231
A family of potassium channel genes related to eag in Drosophila and mammals.
Warmke, J. W., & Ganetzky, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3438 · Cited by 982
Drug induced QT prolongation and torsades de pointes
Yap, Y. G., & Camm, A. J. (2003) · Heart · doi:10.1136/heart.89.11.1363 · Cited by 958
A structural basis for drug-induced long QT syndrome
Mitcheson, J. S., Chen, J., Lin, M., Culberson, C., & Sanguinetti, M. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210244497 · Cited by 944
Crystal Structure of the Potassium Channel KirBac1.1 in the Closed State
Kuo, A., Gulbis, J. M., Antcliff, J. F., Rahman, T., Lowe, E. D., Zimmer, J., Cuthbertson, J., Ashcroft, F. M., Ezaki, T., & Doyle, D. A. (2003) · Science · doi:10.1126/science.1085028 · Cited by 785
The principle of gating charge movement in a voltage-dependent K+ channel
Jiang, Y., Ruta, V., Chen, J., Lee, A., & MacKinnon, R. (2003) · Nature · doi:10.1038/nature01581 · Cited by 781
Papazian, D. M., Schwarz, T. L., Tempel, B. L., Jan, Y. N., & Jan, L. Y. (1987) · Science · doi:10.1126/science.2441470 · Cited by 721
The voltage-gated potassium channels and their relatives
Yellen, G. (2002) · Nature · doi:10.1038/nature00978 · Cited by 706
Long QT syndromes and torsade de pointes
Viskin, S. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02107-8 · Cited by 689
What Clinicians Should Know About the QT Interval
Al-Khatib, S. M., LaPointe, N. M. A., Kramer, J. M., & Califf, R. M. (2003) · JAMA · doi:10.1001/jama.289.16.2120 · Cited by 667
Modeling the Heart--from Genes to Cells to the Whole Organ
Noble, D. (2002) · Science · doi:10.1126/science.1069881 · Cited by 622
Hondeghem, L. M., & Snyders, D. J. (1990) · Circulation · doi:10.1161/01.cir.81.2.686 · Cited by 603
Potassium Channels: Molecular Defects, Diseases, and Therapeutic Opportunities
Shieh, C.-C., Coghlan, M., Sullivan, J. P., & Gopalakrishnan, M. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01469-8 · Cited by 518
Hondeghem, L. M., Carlsson, L., & Duker, G. (2001) · Circulation · doi:10.1161/01.cir.103.15.2004 · Cited by 497
Haverkamp*, W. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00119-x · Cited by 486
A common polymorphism associated with antibiotic-induced cardiac arrhythmia
Sesti, F., Abbott, G. W., Wei, J., Murray, K. T., Saksena, S., Schwartz, P. J., Priori, S. G., Roden, D. M., George, A. L., & Goldstein, S. A. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180223197 · Cited by 479
MacKinnon, R. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01104-9 · Cited by 433
Haverkamp, W. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2249 · Cited by 414
A proton pore in a potassium channel voltage sensor reveals a focused electric field
Starace, D. M., & Bezanilla, F. (2004) · Nature · doi:10.1038/nature02270 · Cited by 398
SINGH, B. N., & WILLIAMS, E. M. V. (1970) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1970.tb09893.x · Cited by 383
Cavalli, A., Poluzzi, E., De Ponti, F., & Recanatini, M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0208875 · Cited by 382
Self-citationMechanism of Block and Identification of the Verapamil Binding Domain to HERG Potassium Channels
Zhang, S., Zhou, Z., Gong, Q., Makielski, J. C., & January, C. T. (1999) · Circulation Research · doi:10.1161/01.res.84.9.989 · Cited by 366
An improved method to correct the QT interval of the electrocardiogram for changes in heart rate
Van de Water, A., Verheyen, J., Xhonneux, R., & Reneman, R. S. (1989) · Journal of Pharmacological Methods · doi:10.1016/0160-5402(89)90015-6 · Cited by 317
Ponti, F. D., Poluzzi, E., Cavalli, A., Recanatini, M., & Montanaro, N. (2002) · Drug Safety · doi:10.2165/00002018-200225040-00004 · Cited by 309
Self-citationIon conduction pore is conserved among potassium channels
Lu, Z., Klem, A. M., & Ramu, Y. (2001) · Nature · doi:10.1038/35101535 · Cited by 307
Molecular Determinants of Dofetilide Block of HERG K+Channels
Ficker, E., Jarolimek, W., Kiehn, J., Baumann, A., & Brown, A. M. (1998) · Circulation Research · doi:10.1161/01.res.82.3.386 · Cited by 286
HERG K+ channels: friend and foe
Vandenberg, J. I., Walker, B. D., & Campbell, T. J. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01662-x · Cited by 284
Spector, P. S., Curran, M. E., Keating, M. T., & Sanguinetti, M. C. (1996) · Circulation Research · doi:10.1161/01.res.78.3.499 · Cited by 283
Kang, J., Wang, L., Chen, X.-L., Triggle, D. J., & Rampe, D. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12364-4 · Cited by 282
Problems of Heart Rate Correction in Assessment of Drug‐Induced QT Interval Prolongation
MALIK, M. (2001) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2001.00411.x · Cited by 276
Evaluation of Drug-Induced QT Interval Prolongation: Implications for Drug Approval and Labelling
Malik, M., & Camm, A. J. (2001) · Drug Safety · doi:10.2165/00002018-200124050-00001 · Cited by 273
Physicochemical Features of the hERG Channel Drug Binding Site
Fernandez, D., Ghanta, A., Kauffman, G. W., & Sanguinetti, M. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310683200 · Cited by 266
Bednar, M. M., Harrigan, E. P., Anziano, R. J., Camm, A. J., & Ruskin, J. N. (2001) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2001.21469 · Cited by 265
Ekins, S., Crumb, W. J., Sarazan, R. D., Wikel, J. H., & Wrighton, S. A. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.427 · Cited by 260
Recent developments in structure-based drug design
Klebe, G. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000084 · Cited by 256
Volders, P. G. A., Sipido, K. R., Vos, M. A., Spätjens, R. L. H. M. G., Leunissen, J. D. M., Carmeliet, E. E., & Wellens, H. J. J. (1999) · Circulation · doi:10.1161/01.cir.100.24.2455 · Cited by 253
Lees-Miller, J. P., Duan, Y., Teng, G. Q., & Duff, H. J. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23209-0 · Cited by 248
Trapping of a Methanesulfonanilide by Closure of the Herg Potassium Channel Activation Gate
Mitcheson, J. S., Chen, J., & Sanguinetti, M. C. (2000) · The Journal of General Physiology · doi:10.1085/jgp.115.3.229 · Cited by 247
PERSPECTIVE: THE SMALL-MOLECULE APPROACH TO BIOLOGY
SCHREIBER (2003) · Chemical & Engineering News Archive · doi:10.1021/cen-v081n009.p051 · Cited by 246
An overview of the potassium channel family.
Miller, C. (2000) · Genome biology · doi:10.1186/gb-2000-1-4-reviews0004 · Cited by 245
QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience
De Ponti, F., Poluzzi, E., & Montanaro, N. (2000) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050714 · Cited by 240
Self-citationSuessbrich, H., Schönherr, R., Heinemann, S. H., Attali, B., Lang, F. J. W., & Busch, A. E. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0700989 · Cited by 229
Milberg, P., Eckardt, L., Bruns, H.-J., Biertz, J., Ramtin, S., Reinsch, N., Fleischer, D., Kirchhof, P., Fabritz, L., Breithardt, G., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.037911 · Cited by 229
Suessbrich, H., Waldegger, S., Lang, F., & Busch, A. E. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00355-9 · Cited by 222
Pearlstein, R. A., Vaz, R. J., Kang, J., Chen, X.-L., Preobrazhenskaya, M., Shchekotikhin, A. E., Korolev, A. M., Lysenkova, L. N., Miroshnikova, O. V., Hendrix, J., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00196-3 · Cited by 222
Chem-Bioinformatics: Comparative QSAR at the Interface between Chemistry and Biology
Hansch, C., Hoekman, D., Leo, A., Weininger, D., & Selassie, C. D. (2002) · Chemical Reviews · doi:10.1021/cr0102009 · Cited by 218
Choe, S. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn727 · Cited by 215
Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes
DARPO, B. (2001) · European Heart Journal Supplements · doi:10.1016/s1520-765x(01)90009-4 · Cited by 205
The rise of computational biology
Noble, D. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm810 · Cited by 192
Tseng, G.-N. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1317 · Cited by 187
Shimizu, W., & Antzelevitch, C. (2000) · Circulation · doi:10.1161/01.cir.102.6.706 · Cited by 182
Ficker, E., Zhao, S., Obejero-Paz, C. A., & Brown, A. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107345200 · Cited by 180
Milnes, J. T., Crociani, O., Arcangeli, A., Hancox, J. C., & Witchel, H. J. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705335 · Cited by 175
Molecular Determinants of Voltage-dependent Human Ether-a-Go-Go Related Gene (HERG) K+ Channel Block
Sánchez-Chapula, J. A., Navarro-Polanco, R. A., Culberson, C., Chen, J., & Sanguinetti, M. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200448200 · Cited by 172
Drug Block of I Kr : Model Systems and Relevance to Human Arrhythmias
Yang, T., Snyders, D., & Roden, D. M. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200111000-00010 · Cited by 171
De Ponti, F., Poluzzi, E., & Montanaro, N. (2001) · European Journal of Clinical Pharmacology · doi:10.1007/s002280100290 · Cited by 171
Self-citationInteractions between S4-S5 Linker and S6 Transmembrane Domain Modulate Gating of HERG K+ Channels
Tristani‐Firouzi, M., Chen, J., & Sanguinetti, M. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200410200 · Cited by 165
Pearlstein, R., Vaz, R., & Rampe, D. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0205651 · Cited by 163
K+ channels as therapeutic drug targets
Wickenden, A. D. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00201-2 · Cited by 160
Gintant, G. A., Limberis, J. T., McDermott, J. S., Wegner, C. D., & Cox, B. F. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200105000-00012 · Cited by 158
WEISSENBURGER, J., Nesterenko, V. V., & Antzelevitch, C. N. (2000) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2000.tb01798.x · Cited by 156
Recanatini, M., Cavalli, A., Belluti, F., Piazzi, L., Rampa, A., Bisi, A., Gobbi, S., Valenti, P., Andrisano, V., Bartolini, M., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990971t · Cited by 156
Self-citationCurrent State and Perspectives of 3D-QSAR
Akamatsu, M. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026023392887 · Cited by 151
Experimental models of torsade de pointes
Eckardt, L. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00043-1 · Cited by 145
Hansch, C. H., & Klein, T. E. (1986) · Accounts of Chemical Research · doi:10.1021/ar00132a003 · Cited by 141
Cavero, I., Mestre, M., Guillon, J.-M., & Crumb, W. (2000) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.5.947 · Cited by 139
Rajamani, S., Anderson, C. L., Anson, B. D., & January, C. T. (2002) · Circulation · doi:10.1161/01.cir.0000019513.50928.74 · Cited by 138
Taglialatela, M., Pannaccione, A., Castaldo, P., Giorgio, G., Zhou, Z., January, C. T., Genovese, A., Marone, G., & Annunziato, L. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.113 · Cited by 133
Hondeghem, L. M., & Hoffmann, P. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200301000-00003 · Cited by 133
Open Channel Block of HERG K+ Channels by Vesnarinone
Kamiya, K., Mitcheson, J. S., Yasui, K., Kodama, I., & Sanguinetti, M. C. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.2.244 · Cited by 131
Potet, F., Bouyssou, T., Escande, D., & Baró, I. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29223-5 · Cited by 128
Pacher, P., Ungvari, Z. I., Nánási, P. P., Fürst, S., & Kecskeméti, V. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220330184544 · Cited by 121
Sotriffer, C., & Klebe, G. (2002) · Il Farmaco · doi:10.1016/s0014-827x(02)01211-9 · Cited by 121
Diochot, S., Loret, E. P., Bruhn, T., Béress, L., & Lazdunski, M. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.1.59 · Cited by 120
Comparative Molecular Similarity Indices Analysis: CoMSIA
Klebe, G. (1998) · Springer eBooks · doi:10.1007/0-306-46858-1_6 · Cited by 119
Sánchez‐Chapula, J. A., Ferrer, T., Navarro‐Polanco, R. A., & Sanguinetti, M. C. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1051 · Cited by 119
Crumb, W., & Cavero, I. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00172-8 · Cited by 118
Witchel, H. J., Milnes, J. T., Mitcheson, J. S., & Hancox, J. C. (2002) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(03)00041-8 · Cited by 118
Hammond, T. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00310-2 · Cited by 117
Molecular Models of Voltage Sensing
Gandhi, C. S., & Isacoff, E. Y. (2002) · The Journal of General Physiology · doi:10.1085/jgp.20028678 · Cited by 117
Molecular biology and the prolonged QT syndromes
Towbin, J. A., & Vatta, M. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00715-4 · Cited by 113
Modelling the heart: insights, failures and progress
Noble, D. (2002) · BioEssays · doi:10.1002/bies.10186 · Cited by 110
The Molecular and Ionic Specificity of Antiarrhythmic Drug Actions
Nattel, S. (1999) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1999.tb00673.x · Cited by 97
Screening lead compounds for QT interval prolongation
Netzer, R., Ebneth, A., Bischoff, U., & Pongs, O. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01602-0 · Cited by 87
QT corrected for heart rate and relation between QT and RR intervals in beagle dogs
Matsunaga, T., Mitsui, T., Harada, T., Inokuma, M., Murano, H., & Shibutani, Y. (1997) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(97)00098-1 · Cited by 85
K+ Channel Structure-Activity Relationships and Mechanisms of Drug-Induced QT Prolongation
Clancy, C. E., Kurokawa, J., Tateyama, M., Wehrens, X. H. T., & Kass, R. S. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140245 · Cited by 78
Answers and Questions from the KvAP Structures
Cohen, B. E., Grabe, M., & Jan, L. Y. (2003) · Neuron · doi:10.1016/s0896-6273(03)00472-0 · Cited by 78
QT lengthening and life-threatening arrhythmias associated with fexofenadine
Pinto, Y. M., Gelder, I. C. V., Heeringa, M. J., & Crijns, H. J. G. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01009-0 · Cited by 78
The HERG K + channel: progress in understanding the molecular basis of its unusual gating kinetics
Kuchel, P. W., Torres, A. M., Campbell, T. J., & Vandenberg, J. I. (2004) · European Biophysics Journal · doi:10.1007/s00249-003-0338-3 · Cited by 68
pH-dependent cocaine-induced cardiotoxicity
Wang, R. Y. (1999) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(99)90088-8 · Cited by 67
Anantharam, A., Lewis, A., Panaghie, G., Gordon, E., McCrossan, Z. A., Lerner, D. J., & Abbott, G. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212751200 · Cited by 66
In silico approaches to predicting drug metabolism, toxicology and beyond
Ekins, S. (2003) · Biochemical Society Transactions · doi:10.1042/bst0310611 · Cited by 62
Cocaine Abuse: Repolarization Abnormalities and Ventricular Arrhythmias
Gamouras, G., Monir, G., Plunkitt, K., Gürsoy, S., & Dreifus, L. S. (2000) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40791-8 · Cited by 58
Scherer, C. R., Lerche, C. J., Decher, N., Dennis, A. T., Maier, P., Ficker, E. K., Busch, A. E., Wollnik, B., & Steinmeyer, K. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704873 · Cited by 56
Drug binding to HERG channels: evidence for a ‘non‐aromatic’ binding site for fluvoxamine
Mitcheson, J. S. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705336 · Cited by 56
The heart of psychotropic drug therapy
Tie, H., Walker, B., Valenzuela, S. M., Breit, S., & Campbell, T. (2000) · The Lancet · doi:10.1016/s0140-6736(05)73083-x · Cited by 52
I Kr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines
Kupershmidt, S., Yang, I. C.-H., Hayashi, K., Wei, J., Chanthaphaychith, S., Petersen, C. I., Johns, D. C., George, A. L., Roden, D. M., & Balser, J. R. (2003) · The FASEB Journal · doi:10.1096/fj.02-1057fje · Cited by 52
ERG Proteins and Functional Cardiac IKr Channels in Rat, Mouse, and Human Heart
Pond, A. L., & Nerbonne, J. M. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00127-x · Cited by 51
Comparison of block among cloned cardiac potassium channels by non-antiarrhythmic drugs
Lacerda, A. E. (2001) · European Heart Journal Supplements · doi:10.1016/s1520-765x(01)90003-3 · Cited by 50
Towards the three-dimensional structure of voltage-gated potassium channels
Choe, S., Kreusch, A., & Pfaffinger, P. J. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01440-1 · Cited by 49
Structural determinants and biophysical properties of HERG and KCNQ1 channel gating
Tristani‐Firouzi, M. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(02)00286-9 · Cited by 49
Moss, A. J., Zareba, C. W., Benhorin, J., Couderc, J., Kennedy, H., Locati, E. H., & Maison‐Blanche, P. (2001) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2001.tb00127.x · Cited by 47
Ponti, F. D., Poluzzi, E., Montanaro, N., & Ferguson, J. (2000) · The Lancet · doi:10.1016/s0140-6736(05)73412-7 · Cited by 43
Self-citationCavalli, A., Greco, G., Novellino, E., & Recanatini, M. (2000) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00203-0 · Cited by 38
Self-citationGenotype and Severity of Long QT Syndrome
Towbin, J. A., Wang, Z., & Li, H. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-0116-gasolq · Cited by 36
Parker, R. B., Perry, G. Y., Horan, L. G., & Flowers, N. C. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199912000-00014 · Cited by 35
Pharmacogenetic Considerations in Diseases of Cardiac Ion Channels
Anantharam, A., Markowitz, S. M., & Abbott, G. W. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.054569 · Cited by 35
Davis, A. S. (1998) · Human & Experimental Toxicology · doi:10.1177/096032719801701205 · Cited by 34
The molecular basis of long QT syndrome and prospects for therapy
Wang, Q. K., Bowles, N. E., & Towbin, J. A. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01320-3 · Cited by 32
Chemistry underlying the cardiotoxicity of antihistamines
Zhang, M.-Q. (1997) · VU Research Portal · Cited by 32
Focus on issues in measuring and interpreting changes in the QTc interval duration
Morganroth, J. (2001) · European Heart Journal Supplements · doi:10.1016/s1520-765x(01)90014-8 · Cited by 29
Ford, J. W., Stevens, E. B., Treherne, J. M., Packer, J. C. L., & Bushfield, M. (2002) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8183-8_4 · Cited by 27
Models for profiling the potential QT prolongation risk of drugs.
MUZIKANT, A. L., & Penland, R. C. (2002) · PubMed · Cited by 25
Fedida, D., Chen, F. S. P., & Zhang, X. (1998) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y98-029 · Cited by 14
Drug-induced torsade de pointes: the perspectives of industry
Carlsson, L. G. (2001) · European Heart Journal Supplements · doi:10.1016/s1520-765x(01)90016-1 · Cited by 12
Isolated tissue models and proarrhythmia
Rosen, M. R. (2001) · European Heart Journal Supplements · doi:10.1016/s1520-765x(01)90008-2 · Cited by 9
Segarra, V., pez, M. L., Ryder, H., Palacios, J. M., & Roberts, D. J. (1999) · Drug Safety · doi:10.2165/00002018-199921001-00007 · Cited by 7
“Are We There Yet?!”: Cardiac Channelopathy and Our Journey Toward Computational Medicine
Mazhari, R. (2002) · Circulation Research · doi:10.1161/01.res.0000018155.62516.a6 · Cited by 3
Cited by
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
hERG potassium channels and cardiac arrhythmia
Sanguinetti, M. C., & Tristani-Firouzi, M. (2006) · Nature · doi:10.1038/nature04710 · Cited by 1,572
Medicinal chemical properties of successful central nervous system drugs
Pajouhesh, H., & Lenz, G. R. (2005) · NeuroRX · doi:10.1602/neurorx.2.4.541 · Cited by 1,535
Farid, R., Day, T., Friesner, R. A., & Pearlstein, R. A. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.12.032 · Cited by 502
Medicinal Chemistry of hERG Optimizations: Highlights and Hang-Ups
Jamieson, C., Moir, E. M., Rankovic, Z., & Wishart, G. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060379l · Cited by 423
Metadata
- Authors
- Recanatini, M., Poluzzi, E., Masetti, M., Cavalli, A., & De Ponti, F.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2004-08-16
- Volume
- 25
- Issue
- 2
- Pages
- 133-166
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W2107375130
- Cited by
- 285
- References
- 131
- FWCI
- 11.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.